Hepatitis C virus clearance and gender.

PubWeight™: 0.80‹?›

🔗 View Article (PMC 1954870)

Published in Gut on June 01, 2007

Authors

T Stroffolini, M Rapicetta, R Di Stefano

Articles by these authors

Efficacy of hepatitis A vaccine in prevention of secondary hepatitis A infection: a randomised trial. Lancet (1999) 3.86

Exposure to foodborne and orofecal microbes versus airborne viruses in relation to atopy and allergic asthma: epidemiological study. BMJ (2000) 2.97

Cross sectional retrospective study of prevalence of atopy among Italian military students with antibodies against hepatitis A virus. BMJ (1997) 2.70

Risk factors in community-acquired chronic hepatitis C virus infection: a case-control study in Italy. J Hepatol (1996) 2.19

Chronic liver disease in the Alexandria governorate, Egypt: contribution of schistosomiasis and hepatitis virus infections. J Hepatol (1997) 1.97

Prevalence, risk factors, and genotype distribution of hepatitis C virus infection in the general population: a community-based survey in southern Italy. Hepatology (1997) 1.96

Hepatitis C virus infection as a risk factor for hepatocellular carcinoma in patients with cirrhosis. A case-control study. Ann Intern Med (1992) 1.92

Changing epidemiology of parenterally transmitted viral hepatitis: results from the hepatitis surveillance system in Italy. Dig Liver Dis (2001) 1.89

Incidence of and risk factors for hepatitis A in Italy: public health indications from a 10-year surveillance. SEIEVA Collaborating Group. J Hepatol (1997) 1.51

A population based survey of hepatitis B virus infection in a southern Italian town. Ital J Gastroenterol Hepatol (1997) 1.49

Hepatitis C virus infection and alanine transaminase levels in the general population: a survey in a southern Italian town. J Hepatol (2000) 1.48

Rate of incidence of hepatocellular carcinoma in patients with compensated viral cirrhosis. Cancer (1999) 1.43

Chronic hepatitis D: a vanishing Disease? An Italian multicenter study. Hepatology (2000) 1.34

Risk factors and outcome among a large patient cohort with community-acquired acute hepatitis C in Italy. Clin Infect Dis (2006) 1.34

Infection rate and spontaneous seroreversion of anti-hepatitis C virus during the natural course of hepatitis C virus infection in the general population. Gut (2002) 1.33

Virologic and clinical expressions of reciprocal inhibitory effect of hepatitis B, C, and delta viruses in patients with chronic hepatitis. Hepatology (2000) 1.26

Distribution of VP7 serotypes and VP4 genotypes among rotavirus strains recovered from Italian children with diarrhea. Arch Virol (1997) 1.23

Heterogeneity of hepatitis C virus genotype 2 variants in West Central Africa (Guinea Conakry). J Gen Virol (1996) 1.21

Glucose tolerance is negatively associated with circulating progenitor cell levels. Diabetologia (2007) 1.21

Correlation between virus genotype and chronicity rate in acute hepatitis C. J Hepatol (1998) 1.20

Long-term course of interferon-treated chronic hepatitis C. J Hepatol (1998) 1.15

Hepatitis C virus infection, HBsAg carrier state and hepatocellular carcinoma: relative risk and population attributable risk from a case-control study in Italy. J Hepatol (1992) 1.15

The changing epidemiology of hepatitis A in Italy. Ital J Gastroenterol (1994) 1.09

Case fatality rate of acute viral hepatitis in Italy: 1995-2000. An update. Dig Liver Dis (2003) 1.09

Diverticular disease as a risk factor for sigmoid colon adenomas. Dig Liver Dis (2002) 1.07

Characterization of Sicilian strains of spotted fever group rickettsiae by using monoclonal antibodies. J Clin Microbiol (1989) 1.06

Measles epidemiology in Italy. Int J Epidemiol (1984) 1.05

Prevalence of antibodies to hepatitis C virus in hepatocellular carcinoma. Lancet (1989) 1.02

Prevention of hepatitis C in Italy: lessons from surveillance of type-specific acute viral hepatitis. SEIEVA collaborating Group. J Viral Hepat (2000) 1.02

Bone marrow of patients with active multiple myeloma: angiogenesis and plasma cell adhesion molecules LFA-1, VLA-4, LAM-1, and CD44. Am J Hematol (1995) 1.01

Dramatic reduction of meningococcal meningitis among military recruits in Italy after introduction of specific vaccination. Vaccine (1993) 1.00

Activation of the ER stress gene gadd153 by hepatitis C virus sensitizes cells to oxidant injury. Virus Res (2007) 0.99

Hepatitis B virus infection in health care workers in Albania: a country still highly endemic for HBV infection. Infection (2007) 0.99

Localization of hepatitis C virus antigens in liver and skin tissues of chronic hepatitis C virus-infected patients with mixed cryoglobulinemia. Hepatology (1995) 0.99

Molecular epidemiology of hepatitis C virus genotype 4 isolates in Egypt and analysis of the variability of envelope proteins E1 and E2 in patients with chronic hepatitis. J Clin Microbiol (2005) 0.99

Fibrin acts as biomimetic niche inducing both differentiation and stem cell marker expression of early human endothelial progenitor cells. Cell Prolif (2011) 0.98

Prevalence of Toxoplasma gondii antibodies among children and teenagers in Italy. Microbiologica (1991) 0.97

Seroepidemiology of pertussis in Italy. Rev Infect Dis (1992) 0.96

Hepatitis B virus infection in Cameroon: a seroepidemiological survey in city school children. J Med Virol (1991) 0.95

Hepatitis-C virus infection in Italy: a multicentric sero-epidemiological study (a report from the HCV study group of the Italian Association for the Study of the Liver). Ital J Gastroenterol (1991) 0.95

Atopy, hygiene, and anthroposophic lifestyle. San Marino Study Group. Lancet (1999) 0.94

Pathogenic factors in cirrhosis with and without hepatocellular carcinoma: a multicenter Italian study. Hepatology (1994) 0.94

Decrease in HDV endemicity in Italy. J Hepatol (1997) 0.94

Baseline seroepidemiology of hepatitis A virus infection among children and teenagers in Italy. Infection (1991) 0.93

Changing epidemiology of hepatitis B in Italy: public health implications. Am J Epidemiol (1992) 0.92

Heterosexual transmission of hepatitis C in Italy. J Med Virol (1999) 0.91

A disturbance of the IL-2/IL-2 receptor system parallels the activity of multiple myeloma. Clin Exp Immunol (1991) 0.90

The epidemiology of hepatitis delta infection in Italy. Promoting Group. J Hepatol (1992) 0.89

Circulating endothelial progenitor cells characterization, function and relationship with cardiovascular risk factors. Curr Pharm Des (2007) 0.89

A comparison of methods for the potency test of rubella vaccine. J Biol Stand (1977) 0.89

Clearance of hepatitis B virus DNA and pre-S surface antigens in patients with markers of acute viral replication. J Med Virol (1989) 0.89

Mutagenesis of hepatitis C virus E1 protein affects its membrane-permeabilizing activity. J Gen Virol (2001) 0.88

Prevalence of non-organ specific autoantibodies in HCV-infected subjects in the general population. Clin Exp Immunol (2003) 0.88

Surveillance of infectious diseases in the Italian military as pre-requisite for tailored vaccination programme. Vaccine (2001) 0.87

Serological survey of hepatitis B infection in Tanzania. Public Health (1994) 0.87

Liver targeting of antiviral nucleoside analogues through the asialoglycoprotein receptor. J Viral Hepat (1997) 0.87

Ethiopian National Hepatitis B Study. J Med Virol (1988) 0.86

Hepatitis C virus RNA profiles in chronically infected individuals: do they relate to disease activity? Hepatology (1999) 0.86

Microbial quality of wastewater: detection of hepatitis A virus by reverse transcriptase-polymerase chain reaction. J Appl Microbiol (2002) 0.86

Exposure to HAV infection in patients with chronic liver disease in Italy, a multicentre study. J Viral Hepat (2006) 0.86

Serological survey of human immunodeficiency virus (HIV) in Ethiopia. J Med Virol (1989) 0.86

Activation of endoplasmic reticulum stress response by hepatitis C virus proteins. Arch Virol (2005) 0.86

The transmembrane domain of hepatitis C virus E1 glycoprotein induces cell death. Virus Res (2004) 0.86

Occult HBV infection and suppression of HCV replication in the early phase of combination therapy for chronic hepatitis C. J Biol Regul Homeost Agents (2003) 0.86

Acute viral hepatitis in childhood: etiology and evolution. J Pediatr Gastroenterol Nutr (1983) 0.85

Substantial decline of notified hepatitis B in major parts of Europe after 1985. Scand J Infect Dis (1994) 0.85

Cell cycle perturbation in a human hepatoblastoma cell line constitutively expressing Hepatitis C virus core protein. Arch Virol (2003) 0.85

Proposal for using tissue culture for the potency test of smallpox vaccine. J Biol Stand (1976) 0.85

Spread of hepatitis C virus infection within families. Investigators of an Italian Multicenter Group. J Viral Hepat (1998) 0.85

Molecular characterisation of HCV genotype 4 isolates circulating in Italy. J Med Virol (2000) 0.85

Endothelial targeting with C1-inhibitor reduces complement activation in vitro and during ex vivo reperfusion of pig liver. Clin Exp Immunol (2001) 0.85

TyG index, HOMA score and viral load in patients with chronic hepatitis C due to genotype 1. J Viral Hepat (2011) 0.84

Activation of the N-myc2 oncogene by woodchuck hepatitis virus integration in the linked downstream b3n locus in woodchuck hepatocellular carcinoma. Virology (1999) 0.84

Prevalence of anti-HCV antibodies in patients with chronic liver disease and its relationship to HBV and HDV infections. Infection (1991) 0.84

Trends in meningococcal disease in Italy in 1986. Public Health (1988) 0.84

Evaluation of antibodies to hepatitis C virus in a long-term prospective study of posttransfusion hepatitis among thalassemic children: comparison between first- and second-generation assay. J Pediatr Gastroenterol Nutr (1993) 0.84

Risk management of HBsAg or anti-HCV positive healthcare workers in hospital. Dig Liver Dis (2001) 0.84

Two phenotypically distinct populations of T cells have suppressor capabilities simultaneously in the maintenance phase of immunologic enhancement. J Immunol (1987) 0.84

Epidemiological and virological characterization of a large community-wide outbreak of hepatitis A in southern Italy. Epidemiol Infect (2007) 0.84

Combined treatment of relapse of chronic hepatitis C with high-dose alpha2b interferon plus ribavirin for 6 or 12 months. J Hepatol (2000) 0.84

Decline in anti-HAV prevalence in the Milan area between 1958 and 1992. Eur J Epidemiol (1994) 0.83

Hepatic steatosis: a specific sign of hepatitis C reinfection after liver transplantation. Liver Transpl Surg (1998) 0.83

Prevalence of TT virus in healthy children and thalassemic pediatric and young adult patients. J Pediatr Gastroenterol Nutr (2001) 0.83

High-dose prolonged combination therapy in non-responders to interferon monotherapy for chronic hepatitis C. Aliment Pharmacol Ther (2001) 0.83

Increased circulating concentrations of interleukin 2 receptor during rejection episodes in heart- or kidney-transplant recipients. Clin Chem (1990) 0.83

Tuberculin skin reactivity in Italian military recruits tested in 1996-1997. Eur J Clin Microbiol Infect Dis (2000) 0.83

An in vitro study on the free radical scavenging capacity of ergothioneine: comparison with reduced glutathione, uric acid and trolox. Biomed Pharmacother (2006) 0.83

Unawareness of HBV infection among inpatients in a Southern Italian hospital. J Viral Hepat (2011) 0.83

Infections caused by Pseudomonas aeruginosa: relatively frequent isolation of serogroup 12 from clinical specimens. Eur J Epidemiol (1985) 0.83

Role of endothelial progenitor cell mobilization after percutaneous angioplasty procedure. Curr Pharm Des (2009) 0.82

Genomic fingerprints and phenotypic characteristics of strains of Neisseria meningitidis causing disease in Italy. Microbiologica (1990) 0.82

Expression and membrane association of hepatitis C virus envelope 1 protein. Virus Genes (2000) 0.82